MedPath

Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis

Conditions
Ureteral Stone
Renal Stone
Registration Number
NCT04871984
Lead Sponsor
University Hospital, Angers
Brief Summary

Holmium laser is the current gold standard for lithotripsy on urinary lithiasis, while Thulium is brand new. The latter has been released in July 2020 in Europe, and only in-vitro studies have been published.

The aim of this study is to compare the stone free rate in ureteroscopy, for all consecutive patients treated with laser fragmentation, between both Holmium and Thulium lasers.

The costs and complications will also be studied.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • renal ou ureteral stone confirmed by an abdominal and pelvic computed tomography
  • treatment with rigid or flexible ureteroscopy
  • laser lithotripsy during the procedure
  • bacteriological examination of urine (sterile, bacterial colonization or treated by antibiotics)
Exclusion Criteria
  • non-use of laser for stone lithotripsy
  • pregnant women
  • under 18 years old
  • refusal to give informed consent
  • urinary malformation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stone free rateThree months after surgery

Urinary tract echography or renal computer tomography imaging. Patients with residual fragments under 4 mm are stone free.

Secondary Outcome Measures
NameTimeMethod
Operating timeImmediately after the intervention

All surgeries are included

Postoperative complicationsUp to three months after surgery

Recording data according to the Clavien classification (rates of hospitalisation, pain, infection and surgical revision)

Perioperative complicationsDuring the intervention

Recording data about ureteric perforation and bleeding

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.